These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 1353877)
1. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry. Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877 [TBL] [Abstract][Full Text] [Related]
2. Adrenal cortical adenoma and adrenal metastasis of renal cell carcinoma: immunohistochemical and DNA ploidy analysis. Kumar D; Kumar S Mod Pathol; 1993 Jan; 6(1):36-41. PubMed ID: 7678935 [TBL] [Abstract][Full Text] [Related]
3. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas. Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953 [TBL] [Abstract][Full Text] [Related]
4. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland. Czyz W; Joensuu H; Pylkkänen L; Klemi PJ J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588 [TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Tanioka F; Hiroi M; Yamane T; Hara H Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885 [TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms. Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646 [TBL] [Abstract][Full Text] [Related]
7. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study. Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093 [TBL] [Abstract][Full Text] [Related]
8. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas]. Mangili F; Sassi I; Schiaffino E; Zogno C; Cantaboni A; Schmid C Pathologica; 1992; 84(1092):459-65. PubMed ID: 1491887 [TBL] [Abstract][Full Text] [Related]
9. [Histology, immunocytochemistry and DNA cytophotometry of adrenocortical tumors--a clinicomorphological study of 72 tumors]. Schröder S; Padberg BC; Achilles E; Lauritzen I; Dralle H; Klöppel G Verh Dtsch Ges Pathol; 1990; 74():284-8. PubMed ID: 1708604 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573 [TBL] [Abstract][Full Text] [Related]
12. Image cytometric DNA analysis of adrenocortical neoplasms as a prognostic parameter: a clinico-pathologic study of 13 patients. Lü X; Stallmach T; Gebbers JO Anal Cell Pathol; 1996 Oct; 12(1):1-11. PubMed ID: 8933905 [TBL] [Abstract][Full Text] [Related]
13. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry. Takehara K; Sakai H; Shono T; Irie J; Kanetake H Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113 [TBL] [Abstract][Full Text] [Related]
15. Proliferative activity and aneuploidy in pleomorphic adenomas of the salivary glands. Martin AR; Mantravadi J; Kotylo PK; Mullins R; Walker S; Roth LM Arch Pathol Lab Med; 1994 Mar; 118(3):252-9. PubMed ID: 7907855 [TBL] [Abstract][Full Text] [Related]
16. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2. Dabbs DJ Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697 [TBL] [Abstract][Full Text] [Related]
18. DNA flow cytometry of endoscopically examined colorectal adenomas and adenocarcinomas. Giaretti W; Sciallero S; Bruno S; Geido E; Aste H; Di Vinci A Cytometry; 1988 May; 9(3):238-44. PubMed ID: 3378458 [TBL] [Abstract][Full Text] [Related]
19. [Flow-cytometric study of the DNA content in adrenal cortex tumors]. Tóth M; Molnár G; Schaff Z; Rácz K; Kiss R; Fütö L; Varga I; Gláz E; Lapis K Orv Hetil; 1993 Jun; 134(26):1411-5. PubMed ID: 8332362 [TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma. Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]